Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT)

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5635392
A conjugated bile acid, 23-selena-25-homotaurocholic acid (SeHCAT), labeled with the gamma emitter Se-75, has been evaluated in man. Absorption and excretion were compared with that of simultaneously administered (23-/sup 14/C)cholic acid. SeHCAT is absorbed quantitatively following oral administration, secreted into the bile at the same rate as cholic acid, reabsorbed from the small intestine, and resecreted. It is not absorbed when the terminal ileum has been excised or bypassed. SeHCAT is therefore the first of a new class of radiopharmaceuticals, namely, gamma-emitting tracers of the complete cycle of the enterohepatic circulation. Its use will simplify investigation of the functional state of the terminal ileum by eliminating the need to collect and process feces.
Research Organization:
Western General Hospital, Edinburgh, Scotland
OSTI ID:
5635392
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 23:2; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT)
Journal Article · Sun Jan 31 23:00:00 EST 1982 · J. Nucl. Med.; (United States) · OSTI ID:5478227

Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment
Journal Article · Fri Dec 31 23:00:00 EST 1982 · Gastroenterology; (United States) · OSTI ID:6377777

Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. [Rats]
Journal Article · Sat Aug 01 00:00:00 EDT 1981 · J. Nucl. Med.; (United States) · OSTI ID:6293023